Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Anti-K vitamins].

D Vergoz

    Phlebologie
    |January 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Antivitamins K are preferred for long-term anticoagulation due to oral administration and infrequent lab monitoring. Understanding physiological factors like gut flora and diuresis is crucial for effective VKA therapy and thrombosis management.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Some surgical aspects of portal hypertension].

    Pathologie et biologie·2014
    Same author

    Overall study of the in vitro plasma clotting system in an invertebrate, Liocarcinus puber (Crustacea Decapoda): considerations on the structure of the Crustacea plasma fibrinogen in relation to evolution.

    Journal of invertebrate pathology·1989
    Same author

    [Thrombogenic abnormalities of hemostasis. Practical implications].

    Phlebologie·1985
    Same author

    [Antithrombin III deficiency induced by heparin and constitutional protein C deficiency. Apropos of a case].

    Phlebologie·1985
    Same author

    [A case of dysfibrinogenemia complicated by hemorrhage and thrombosis].

    Phlebologie·1985
    Same author

    Immunoglobulin G antibodies to lymphadenopathy-associated virus in differently treated French and Belgian hemophiliacs.

    Annals of internal medicine·1985
    Same journal

    [Effect of veinotonyl 75 on the capillary permeability test using technetium albumin in cyclic orthostatic edemas].

    Phlebologie·1993
    Same journal

    [Variceal thromboses, their ambulatory treatment].

    Phlebologie·1993
    Same journal

    [Endoscopic treatment of perforating veins--current data].

    Phlebologie·1993
    Same journal

    [Program for the development and storing of images].

    Phlebologie·1993
    Same journal

    [Neutrophil activation in experimental venous hypertension].

    Phlebologie·1993
    Same journal

    [Is duplex echography mandatory in cases of deep venous insufficiency?].

    Phlebologie·1993
    See all related articles

    Area of Science:

    • Pharmacology
    • Hematology
    • Microbiology

    Context:

    • Oral anticoagulants, specifically antivitamins K (VKAs), are widely used for extended treatment durations.
    • Their use is favored due to convenient oral administration, less frequent laboratory monitoring compared to other anticoagulants, and a lack of superior alternatives for managing thrombosis.
    • Physiological factors such as alterations in intestinal microbial flora and pathological changes in diuresis significantly influence VKA efficacy.

    Purpose:

    • To elucidate the physiological mechanisms affecting the anticoagulant action of antivitamins K.
    • To highlight the importance of this knowledge for national treatment protocols.
    • To address practical challenges in laboratory monitoring for VKA therapy.

    Summary:

    • Antivitamins K are essential for long-term anticoagulation, with their action influenced by gut microbiota and diuresis.

    Related Experiment Videos

  • Effective VKA therapy requires understanding these physiological interactions for optimal patient management.
  • While laboratory surveillance is necessary, practical issues persist, making Quick time determination the most feasible monitoring method.

    • Impact:

    • Provides essential knowledge for optimizing national VKA treatment strategies.
    • Identifies practical challenges in laboratory monitoring, emphasizing the need for standardized procedures.
    • Facilitates better regulation of VKA therapy, especially in patients also receiving heparin, by enabling precise monitoring of prothrombin complex constituents.